BIT has better prospects IMO:
Sydney - Thursday - September 8: (RWE Aust Business News) -
Biotron Ltd (ASX:BIT) has had a lead compound selected for clinical
trials in HIV treatment.
The trials of the selected drug BIT225 are expected to commence
in the first half of 2006.
Biotron shares were up 3c at 19c
- Forums
- ASX - By Stock
- CTF
- ignorance from some it would appear...
CTF
citrofresh international limited
ignorance from some it would appear..., page-4
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Currently unlisted public company.
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online